Riskpilot← Back to searchSign inGet full accessBiosensor Applications International AB
ABActiveOrg 5566703350Karins Väg 5Manufacture of pharmaceutical preparations · NACE 2120Est. 20042 employees
Revenue 2024
SEK 2,5M
-63% vs 2023
EBITDA margin
-39.3%
-224% vs 2023
Equity ratio
16.7%
Financial strength
Net profit 2024
SEK -1M
-226% vs 2023
| Revenue | SEK 2,5M | -63% |
| EBITDA | SEK -993K | -224% |
| Net profit | SEK -1M | -226% |
| Total assets | SEK 2,3M | -54% |
| Equity | SEK 379K | -61% |
| Employees | 2 | — |
Legal name
Biosensor Applications International AB
Org number
5566703350
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
10 november 2004
Share capital
SEK 199 900
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av Johansson, Carl Jakob Vojbacke, Lars Fredrik
Company purpose
Bolagets verksamhet är att utveckla, tillverka och bedriva handel med avancerade biosensorsystem för detektering av extremt små mängder av olika ämnen i gasform, äga och förvalta fast och lös egendom samt bedriva andra därmed förenliga verksamheter.
Address
Karins Väg 5
Phone
+4670990463
Email
info@biosensor.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 2 690 | 4 071 | 3 739 | — | 4 700 | 6 890 | 2 525 |
| Staff expenses | — | — | — | — | — | — | — | — | −1 250 | −1 022 |
| EBITDA | 2 423 | −909 | −1 076 | −644 | 233 | −2 598 | 0 | −2 208 | 799 | −993 |
| Depreciation & amort. | −1 149 | −1 149 | −1 107 | −0 | −0 | −0 | — | −0 | −5 | −13 |
| EBIT | 1 274 | −2 058 | −2 183 | −644 | 233 | −2 598 | 0 | −2 208 | 794 | −1 006 |
| Net financials | 15 | 185 | −2 | −2 | 2 | 6 | — | −6 | 1 | 1 |
| Profit before tax | 18 469 | −1 873 | −2 185 | −646 | 235 | −2 592 | 0 | −2 248 | 795 | −1 005 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 | — | — |
| Net profit | 18 469 | −1 873 | −2 185 | −646 | 235 | −2 592 | — | −2 248 | 795 | −1 005 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 23 739 | 16 327 | 14 433 | 14 013 | 5 150 | 4 573 | — | 2 781 | 4 902 | 2 271 |
| Equity | 22 447 | 15 573 | 13 388 | 12 742 | 2 607 | 66 | — | 190 | 985 | 379 |
| Long-term debt | 0 | 0 | 0 | 78 | 242 | 1 937 | — | 1 404 | 2 687 | 701 |
| Short-term debt | 1 292 | 754 | 1 045 | 1 193 | 2 301 | 2 570 | — | 1 187 | 1 230 | 1 191 |
| Total debt | 1 292 | 754 | 1 045 | 1 271 | 2 543 | 4 507 | — | 2 591 | 3 917 | 1 892 |
EBITDA margin
-39.3%
This company
15.8%
Market median
-349% vs market
20152024
Equity ratio
16.7%
This company
38.2%
Market median
-56% vs market
20152024
Return on equity
-265.0%
This company
18.4%
Market median
-1540% vs market
20152024
Net profit margin
-39.8%
This company
8.1%
Market median
-591% vs market
20152024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20152024
Debt / equity
4.99×
This company
0.62×
Market median
-705% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ITERATA AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ITERATA AB
Biosensor Applications International AB Board members of Biosensor Applications International AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Carl Gustav Nygren | Deputy Board Member | 0 companies |
| Carl Jakob Johansson | Board of Directors | 0 companies |
| Lars Fredrik Vojbacke | Chairman | 0 companies |